Mycophenolate mofetil Withdrawn Phase 2 Trials for Neuroblastomas Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00874315Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.